Company intelligence / Profile preview

C Technologies

Bridgewater, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

C Technologies was a private life science tools company focused on analytical instrumentation for biopharmaceutical development and manufacturing. The company designed and manufactured fiber-optic assemblies, spectroscopy instrumentation, and process analytics systems used primarily by biotech and pharmaceutical customers, with a particular strength in protein concentration measurement for biologics. Its flagship SoloVPE platform used patented Variable Pathlength Technology and Slope Spectroscopy to enable rapid UV/Vis concentration analysis without dilution. C Technologies was acquired by Repligen in 2019 for approximately $240 million and its technology continues to be commercialized within Repligen's process analytics portfolio.

Industry: Non-Drug Biotech

Beyond the preview

Go deeper on C Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on C Technologies.

Explore the full profile